Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias

Item Type:Article
Title:Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias
Creators Name:Massenkeil, G. and Nagy, M. and Neuburger, S. and Tamm, I. and Lutz, C. and Le Coutre, P. and Rosen, O. and Wernecke, K.D. and Doerken, B. and Arnold, R.
Abstract:To assess the role of allogeneic stem cell transplantation (SCT) after reduced-intensity conditioning (RIC) in acute leukaemias, we retrospectively compared 25 patients with acute lymphoblastic leukaemia or acute myelogenous leukaemia after RIC to a historical group of 50 matched controls after high-dose conditioning. Engraftment, acute GvHD and severe infections were comparable in both groups. During the observation period, 1/25 patients (4%) after RIC and 14/50 (28%) after standard SCT died due to transplant-related causes; cumulative nonrelapse mortality (NRM) was 4% after RIC and 24% after standard SCT (P=0.029). In total, 15/25 patients (60%) relapsed after RIC and 20/50 (40%) after standard SCT; probability of disease-free survival (DFS) at 3 years was 43% after RIC and 49% after standard SCT (NS). Overall survival (OS) was 40% after RIC and 37% after standard SCT (NS). Stage of disease, cytogenetic risk profile, acute and chronic GvHD, chimerism status at day 90 and severe infections after transplantation were risk factors with significant impact on DFS and/or OS. In retrospective analysis, patients with acute leukaemias who receive RIC because of contraindications against standard SCT have a comparable outcome to standard SCT, but the higher relapse rate warrants further studies.
Keywords:Reduced-Intensity Conditioning, Nonmyeloablative Stem Cell Transplantation, Standard High-Dose Conditioning, ALL, AML
Source:Bone Marrow Transplantation
ISSN:0268-3369
Publisher:Nature Publishing Group (U.K.)
Volume:36
Page Range:683-689
Date:22 August 2005
Official Publication:https://doi.org/10.1038/sj.bmt.1705123
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library